These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 24325272)
1. Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. Kwak HW; Park JW; Nam BH; Yu A; Woo SM; Kim TH; Kim SH; Koh YH; Kim HB; Park SJ; Lee WJ; Hong EK; Kim CM J Gastroenterol Hepatol; 2014 Apr; 29(4):820-9. PubMed ID: 24325272 [TBL] [Abstract][Full Text] [Related]
2. Survival analysis of 904 patients with hepatocellular carcinoma in a hepatitis B virus-endemic area. Park KW; Park JW; Choi JI; Kim TH; Kim SH; Park HS; Lee WJ; Park SJ; Hong EK; Kim CM J Gastroenterol Hepatol; 2008 Mar; 23(3):467-73. PubMed ID: 17764529 [TBL] [Abstract][Full Text] [Related]
3. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area. Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761 [TBL] [Abstract][Full Text] [Related]
4. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study. Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197 [TBL] [Abstract][Full Text] [Related]
5. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma. Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297 [TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort. Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403 [TBL] [Abstract][Full Text] [Related]
7. Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma. Chan SL; Mo F; Johnson P; Li L; Tang N; Loong H; Chan AW; Koh J; Chan AT; Yeo W J Gastroenterol Hepatol; 2015 Oct; 30(10):1529-35. PubMed ID: 25968302 [TBL] [Abstract][Full Text] [Related]
8. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging. Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792 [TBL] [Abstract][Full Text] [Related]
9. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma. Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688 [TBL] [Abstract][Full Text] [Related]
10. Prognosis predictability of hepatocellular carcinoma according to staging systems in hepatitis B virus-endemic area. Kang HY; Shin HD; Kim SB; Song IH Clin Res Hepatol Gastroenterol; 2012 Aug; 36(4):357-64. PubMed ID: 22326248 [TBL] [Abstract][Full Text] [Related]
11. Prognosis evaluation in alpha-fetoprotein negative hepatocellular carcinoma after hepatectomy: comparison of five staging systems. Zhang XF; Qi X; Meng B; Liu C; Yu L; Wang B; Lv Y Eur J Surg Oncol; 2010 Aug; 36(8):718-24. PubMed ID: 20538423 [TBL] [Abstract][Full Text] [Related]
12. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis. Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644 [TBL] [Abstract][Full Text] [Related]
13. NIACE score for hepatocellular carcinoma patients treated by surgery or transarterial chemoembolization. Adhoute X; Pénaranda G; Raoul JL; Bollon E; Pol B; Letreut YP; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Hardwigsen J; Lefolgoc G; Castellani P; Bronowicki JP; Bourlière M Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):706-715. PubMed ID: 28195873 [TBL] [Abstract][Full Text] [Related]
14. Treatment of hepatocellular carcinoma in a tertiary Romanian center. Deviations from BCLC recommendations and influence on survival rate. Radu P; Groza I; Iancu C; Al Hajjar N; Andreica V; Sparchez Z J Gastrointestin Liver Dis; 2013 Sep; 22(3):291-7. PubMed ID: 24078986 [TBL] [Abstract][Full Text] [Related]
15. Validation and modification of a proposed substaging system for patients with intermediate hepatocellular carcinoma. Wang JH; Kee KM; Lin CY; Hung CH; Chen CH; Lee CM; Lu SN J Gastroenterol Hepatol; 2015 Feb; 30(2):358-63. PubMed ID: 25088668 [TBL] [Abstract][Full Text] [Related]
16. Differences in surgical outcomes between hepatitis B- and hepatitis C-related hepatocellular carcinoma: a retrospective analysis of a single North American center. Franssen B; Alshebeeb K; Tabrizian P; Marti J; Pierobon ES; Lubezky N; Roayaie S; Florman S; Schwartz ME Ann Surg; 2014 Oct; 260(4):650-6; discussion 656-8. PubMed ID: 25203882 [TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre. Grieco A; Pompili M; Caminiti G; Miele L; Covino M; Alfei B; Rapaccini GL; Gasbarrini G Gut; 2005 Mar; 54(3):411-8. PubMed ID: 15710992 [TBL] [Abstract][Full Text] [Related]
18. External validation of a simplified BCLC staging system for early hepatocellular carcinoma. Santambrogio R; Salceda J; Costa M; Kluger MD; Barabino M; Laurent A; Opocher E; Azoulay D; Cherqui D Eur J Surg Oncol; 2013 Aug; 39(8):850-7. PubMed ID: 23726257 [TBL] [Abstract][Full Text] [Related]
19. Survival outcomes in patients with advanced hepatocellular carcinoma treated with drug-eluting bead chemoembolization. Ray CE; Brown AC; Green TJ; Winston H; Curran C; Kreidler SM; Glueck DH; Rochon PJ AJR Am J Roentgenol; 2015 Feb; 204(2):440-7. PubMed ID: 25615768 [TBL] [Abstract][Full Text] [Related]
20. Barcelona Clinic Liver Cancer staging and transplant survival benefit for patients with hepatocellular carcinoma: a multicentre, cohort study. Vitale A; Morales RR; Zanus G; Farinati F; Burra P; Angeli P; Frigo AC; Del Poggio P; Rapaccini G; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Giannini EG; Caturelli E; Chiaramonte M; Trevisani F; Cillo U; Lancet Oncol; 2011 Jul; 12(7):654-62. PubMed ID: 21684210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]